CA2557301A1 - Groupes cyclobutenedione contenant des composes servant d'inhibiteurs a la serine protease ns3 du virus de l'hepatite c - Google Patents
Groupes cyclobutenedione contenant des composes servant d'inhibiteurs a la serine protease ns3 du virus de l'hepatite c Download PDFInfo
- Publication number
- CA2557301A1 CA2557301A1 CA002557301A CA2557301A CA2557301A1 CA 2557301 A1 CA2557301 A1 CA 2557301A1 CA 002557301 A CA002557301 A CA 002557301A CA 2557301 A CA2557301 A CA 2557301A CA 2557301 A1 CA2557301 A1 CA 2557301A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- group
- alkyl
- hcv
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 CC(C)C(C(C1=O)=O)=C1N(C)C[C@@](C(C)(C)C)NC(N[C@@](C(C)(C)C)C(N(C[C@@](C1)*(C)C)[C@@]1C(NC(CC1CC1)C(C(N*)=O)=O)=O)=O)=O Chemical compound CC(C)C(C(C1=O)=O)=C1N(C)C[C@@](C(C)(C)C)NC(N[C@@](C(C)(C)C)C(N(C[C@@](C1)*(C)C)[C@@]1C(NC(CC1CC1)C(C(N*)=O)=O)=O)=O)=O 0.000 description 2
- NTUBTQQUFMODES-QHSCAFSZSA-N CC(C)(C)[C@@H](CNC(C1=O)=C(C2CC2)C1=O)NC(N[C@@H](C(C)(C)C)C(N(CC1)C(C(NC(CC2CCC2)C(C(N)=O)=O)=O)C1=[F](C)C)=O)=O Chemical compound CC(C)(C)[C@@H](CNC(C1=O)=C(C2CC2)C1=O)NC(N[C@@H](C(C)(C)C)C(N(CC1)C(C(NC(CC2CCC2)C(C(N)=O)=O)=O)C1=[F](C)C)=O)=O NTUBTQQUFMODES-QHSCAFSZSA-N 0.000 description 1
- UPWXQYRODBSCDQ-BJYQXZSCSA-N CC(C)C[C@@H](CC1)[C@@H](C(NCC(C(NC)=O)=O)=O)N1C([C@H](C(C)(C)C)NC(N[C@H](CNC(C(C1=O)=O)=C1N(C)C)C(C)(C)C)=O)=O Chemical compound CC(C)C[C@@H](CC1)[C@@H](C(NCC(C(NC)=O)=O)=O)N1C([C@H](C(C)(C)C)NC(N[C@H](CNC(C(C1=O)=O)=C1N(C)C)C(C)(C)C)=O)=O UPWXQYRODBSCDQ-BJYQXZSCSA-N 0.000 description 1
- RFYBHBJEITZLDH-IPTNVUIUSA-N CC(C)[C@H](C[C@H]1C(NC(CCC#C)C(C(NCC=C)=O)=O)=O)CN1C([C@H](C1CCCCC1)NC(N[C@H](CN(C)C(C(C1=O)=O)=C1N(C)C)C1CCCCC1)=O)=O Chemical compound CC(C)[C@H](C[C@H]1C(NC(CCC#C)C(C(NCC=C)=O)=O)=O)CN1C([C@H](C1CCCCC1)NC(N[C@H](CN(C)C(C(C1=O)=O)=C1N(C)C)C1CCCCC1)=O)=O RFYBHBJEITZLDH-IPTNVUIUSA-N 0.000 description 1
- GYCSZGRZZMAWPH-SANXVGBMSA-N CCCC(C(C(NCC=C)=O)=O)NC([C@H](C[C@H](C1)/C(/C)=C/C)N1C([C@H](C1CCCCC1)NC(N[C@H](CN(C)C(C1=O)=C(C2(C)CC2)C1=O)C(C)(C)C)=O)=O)=O Chemical compound CCCC(C(C(NCC=C)=O)=O)NC([C@H](C[C@H](C1)/C(/C)=C/C)N1C([C@H](C1CCCCC1)NC(N[C@H](CN(C)C(C1=O)=C(C2(C)CC2)C1=O)C(C)(C)C)=O)=O)=O GYCSZGRZZMAWPH-SANXVGBMSA-N 0.000 description 1
- XSDRDPJXSVKKQN-HBAIKHLUSA-N CCCC(C(C(NCC=C)=O)=O)NC([C@H]([C@H](CC1)C(C)C)N1C([C@H](C(C)(C)C)NC(N[C@H](CCCC(CC)C(C1=O)=C(C)C1=O)C(C)(C)C)=O)=O)O Chemical compound CCCC(C(C(NCC=C)=O)=O)NC([C@H]([C@H](CC1)C(C)C)N1C([C@H](C(C)(C)C)NC(N[C@H](CCCC(CC)C(C1=O)=C(C)C1=O)C(C)(C)C)=O)=O)O XSDRDPJXSVKKQN-HBAIKHLUSA-N 0.000 description 1
- ZDFFDVBMVFQQOP-MYWVDXEWSA-N CCNC(C(C(CC1CC1)NC([C@H]1N(C[C@H](C(C)(C)C)NC(N[C@H](CN(C)C(C(C2=O)=O)=C2N(C)C)C(C)(C)C)=O)CCC1C(C)C)=O)=O)=O Chemical compound CCNC(C(C(CC1CC1)NC([C@H]1N(C[C@H](C(C)(C)C)NC(N[C@H](CN(C)C(C(C2=O)=O)=C2N(C)C)C(C)(C)C)=O)CCC1C(C)C)=O)=O)=O ZDFFDVBMVFQQOP-MYWVDXEWSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54842304P | 2004-02-27 | 2004-02-27 | |
| US60/548,423 | 2004-02-27 | ||
| PCT/US2005/006083 WO2005085197A1 (fr) | 2004-02-27 | 2005-02-24 | Groupes cyclobutenedione contenant des composes servant d'inhibiteurs a la serine protease ns3 du virus de l'hepatite c |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2557301A1 true CA2557301A1 (fr) | 2005-09-15 |
Family
ID=34919362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002557301A Abandoned CA2557301A1 (fr) | 2004-02-27 | 2005-02-24 | Groupes cyclobutenedione contenant des composes servant d'inhibiteurs a la serine protease ns3 du virus de l'hepatite c |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1742914A1 (fr) |
| JP (1) | JP2007525521A (fr) |
| CN (1) | CN1946690A (fr) |
| CA (1) | CA2557301A1 (fr) |
| WO (1) | WO2005085197A1 (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006130552A2 (fr) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Methodes de traitement du virus de l'hepatite c |
| US20060275366A1 (en) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Controlled-release formulation |
| US20060281689A1 (en) * | 2005-06-02 | 2006-12-14 | Schering Corporation | Method for modulating activity of HCV protease through use of a novel HCV protease inhibitor to reduce duration of treatment period |
| US20060276404A1 (en) * | 2005-06-02 | 2006-12-07 | Anima Ghosal | Medicaments and methods combining a HCV protease inhibitor and an AKR competitor |
| US20070021351A1 (en) * | 2005-06-02 | 2007-01-25 | Schering Corporation | Liver/plasma concentration ratio for dosing hepatitis C virus protease inhibitor |
| US20060276407A1 (en) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Methods of treating hepatitis C virus |
| AU2006252623A1 (en) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Controlled-release formulation useful for treating disorders associated with hepatitis C virus |
| PL1966130T3 (pl) | 2005-12-23 | 2014-05-30 | Zealand Pharma As | Zmodyfikowane związki mimetyczne lizyny |
| US7816348B2 (en) | 2006-02-03 | 2010-10-19 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| KR20090042973A (ko) | 2006-08-17 | 2009-05-04 | 베링거 인겔하임 인터내셔날 게엠베하 | 바이러스 폴리머라제 억제제 |
| EP2468724B1 (fr) | 2006-12-21 | 2015-11-18 | Zealand Pharma A/S | Synthèse de composés de pyrrolidine |
| WO2009018657A1 (fr) | 2007-08-03 | 2009-02-12 | Boehringer Ingelheim International Gmbh | Inhibiteurs de polymerase virale |
| EP2234977A4 (fr) | 2007-12-19 | 2011-04-13 | Boehringer Ingelheim Int | Inhibiteurs de polymérase virale |
| AU2010203656A1 (en) | 2009-01-07 | 2011-07-21 | Scynexis, Inc. | Cyclosporine derivative for use in the treatment of HCV and HIV infection |
| CN103387510B (zh) * | 2013-08-08 | 2015-09-09 | 苏州永健生物医药有限公司 | 一种β-氨基-alpha-羟基环丁基丁酰胺盐酸盐的合成方法 |
| DK3618847T3 (da) | 2017-05-05 | 2021-05-25 | Boston Medical Ct Corp | GAP-junction-modulatorer af intercellulær kommunikation og deres anvendelse til behandling af diabetisk øjensygdom |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5168103A (en) * | 1991-01-22 | 1992-12-01 | American Home Products Corporation | [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl) amino]alkyl]-acid derivatives |
| US6323180B1 (en) * | 1998-08-10 | 2001-11-27 | Boehringer Ingelheim (Canada) Ltd | Hepatitis C inhibitor tri-peptides |
| UA74546C2 (en) * | 1999-04-06 | 2006-01-16 | Boehringer Ingelheim Ca Ltd | Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition |
| ATE297946T1 (de) * | 2000-04-03 | 2005-07-15 | Vertex Pharma | Inhibitoren von serin proteasen, speziell der hepatitis-c-virus ns3-protease |
| BR0112666A (pt) * | 2000-07-21 | 2003-06-10 | Schering Corp | Peptìdeos como inibidores de ns3-serina protease de vìrus da hepatite c |
| US7244721B2 (en) * | 2000-07-21 | 2007-07-17 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| DK1385870T3 (da) * | 2000-07-21 | 2010-07-05 | Schering Corp | Peptider som inhibitorer af NS3-serinprotease fra hepatitis C-virus |
| EP1358160A1 (fr) * | 2001-02-07 | 2003-11-05 | Abbott Laboratories | Diones aminales utilisees en tant qu'agents d'ouverture des canaux potassiques |
| US20040106794A1 (en) * | 2001-04-16 | 2004-06-03 | Schering Corporation | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| DK1381590T3 (da) * | 2001-04-16 | 2007-10-22 | Schering Corp | 3,4-disubstituerede cyclobuten-1,2-dioner som CXC-kemokinreceptorligander |
-
2005
- 2005-02-24 CN CNA2005800126511A patent/CN1946690A/zh active Pending
- 2005-02-24 EP EP05723791A patent/EP1742914A1/fr not_active Withdrawn
- 2005-02-24 JP JP2007501006A patent/JP2007525521A/ja active Pending
- 2005-02-24 CA CA002557301A patent/CA2557301A1/fr not_active Abandoned
- 2005-02-24 WO PCT/US2005/006083 patent/WO2005085197A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005085197A1 (fr) | 2005-09-15 |
| JP2007525521A (ja) | 2007-09-06 |
| CN1946690A (zh) | 2007-04-11 |
| EP1742914A1 (fr) | 2007-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1939213B1 (fr) | Nouveaux composés en tant qu'inhibiteurs de la sérine protéase NS3 du virus de l'hépatite C | |
| EP1737821B1 (fr) | Composes de proline fusionnes a 3,4-(cyclopentyl) en tant qu'inhibiteurs de la protease serine ns3 du virus de l'hepatite c | |
| US7635694B2 (en) | Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease | |
| EP1773868B1 (fr) | Prolines substituées en tant qu`inhibiteurs de la sérine protéase du virus ns3 de l`hépatite c | |
| US7423058B2 (en) | Inhibitors of hepatitis C virus NS3 protease | |
| EP1730142B1 (fr) | Nouveaux cetoamides a p4 cycliques en tant qu'inhibiteurs de la ns3 serine protease du virus de l'hepatite c | |
| CA2557301A1 (fr) | Groupes cyclobutenedione contenant des composes servant d'inhibiteurs a la serine protease ns3 du virus de l'hepatite c | |
| EP1748983A2 (fr) | Nouveaux composes en tant qu'inhibiteurs de la protease serine ns3 du virus de l'hepatite c | |
| CA2549167A1 (fr) | Inhibiteurs de la protease serine ns3/ns4a du virus de l'hepatite c (hcv) | |
| EP1730110A1 (fr) | Composes soufres en tant qu'inhibiteurs de la protease serine ns3 du virus de l'hepatite c | |
| MXPA06009809A (en) | Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease | |
| MXPA06009812A (en) | Novel compounds as inhibitors of hepatitis c virus ns3 serine protease | |
| MXPA06009815A (en) | 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease | |
| MXPA06009811A (en) | Compounds as inhibitors of hepatitis c virus ns3 serine protease | |
| MXPA06009814A (en) | Inhibitors of hepatitis c virus ns3 protease | |
| MXPA06009810A (en) | Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |
Effective date: 20130225 |